Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Research and development method of siRNA for COVID-19 virus drug therapy

A technology for COVID-19 and viruses, which is applied in the field of siRNA research and development for COVID-19 virus drug treatment, and can solve problems such as the inability to quantitatively evaluate the efficiency of candidate siRNA sequences

Active Publication Date: 2020-06-30
JILIN UNIV
View PDF9 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The main purpose of the present invention is to solve the problem that the rule-based design method cannot quantitatively evaluate the efficiency of candidate siRNA sequences;

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Research and development method of siRNA for COVID-19 virus drug therapy
  • Research and development method of siRNA for COVID-19 virus drug therapy
  • Research and development method of siRNA for COVID-19 virus drug therapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0080] see Figure 1 to Figure 2 Shown:

[0081] The siRNA research and development method for COVID-19 virus drug treatment provided by the present invention, its method is as follows:

[0082] The siRNA research and development method includes two parts: preliminary screening and machine learning model prediction and selection. The specific steps are as follows:

[0083] The first part: the preliminary screening of potential high-efficiency siRNA based on multiple indicators, the specific steps are as follows:

[0084] Step 1. Select the S gene sequence in the COVID-19 virus genome as the target sequence, and perform multiple sequence comparison analysis on the genomes of all other mutant strains of the COVID-19 virus to determine the conserved region of the target target sequence;

[0085] Step 2, search the gene coding sequence of the conserved region of the target target sequence for a 19nt long nucleotide subsequence, and obtain the corresponding siRNA duplex according...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a research and development method of siRNA for COVID-19 virus drug therapy, which comprises: a first part of preliminarily screening potential high-efficiency siRNA based on multiple indexes, which specifically comprises the following steps: step 1, selecting an S gene sequence as a target sequence; step 2, obtaining a corresponding siRNA double strand; step 3, screening asiRNA sequence with a concentration of 36 to 53%; step 4, screening out siRNA with free energy; step 5, defining and calculating an index I; step 6, screening out siRNA of the first 50%; step 7, defining and calculating an index II; step 8, screening out siRNA with the index II being equal to 5; step 9, defining and calculating an index III; step 10, ranking the first 50% of siRNA; step 11, directly taking all the candidate siRNAs selected in the step 10; step 12, specifically targeting a target sequence; step 13, taking the remaining siRNA as the siRNA subjected to preliminary screening; anda second part of performing interference efficiency prediction and optimization by using a machine learning model. The method has the beneficial effect of realizing safe, reliable and high-interference-efficiency siRNA design.

Description

technical field [0001] The present invention relates to an siRNA research and development method for drug treatment, in particular to a siRNA research and development method for COVID-19 virus drug treatment. Background technique [0002] At present, RNA interference technology is an effective gene research tool developed in recent years. Its wide application has accelerated the pace of functional genomics research and also promoted research in related fields such as gene therapy. A key factor affecting the efficiency of RNA interference is the design of the siRNA sequence. RNA interference technology requires that the siRNA sequence and the mRNA sequence at the target site must be strictly matched, and a single base mismatch may cause RNA interference to fail. Therefore, designing an effective siRNA sequences can increase the efficiency of gene silencing. A large number of experiments have shown that the effect of siRNA designed for the same target mRNA varies greatly, bec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G16B40/00G16B30/00G16B15/30
CPCG16B15/30G16B30/00G16B40/00
Inventor 朱晓冬陈梦欣刘元宁张浩
Owner JILIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com